Authors:
ROBICHAUD A
TATTERSALL FD
CHOUDHURY I
RODGER IW
Citation: A. Robichaud et al., EMESIS INDUCED BY INHIBITORS OF TYPE-IV CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE (PDE IV), Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 2211-2211
Authors:
HALE JJ
MILLS SG
MACCOSS M
FINKE PE
CASCIERI MA
SADOWSKI S
BER E
CHICCHI GG
KURTZ M
METZGER J
EIERMANN G
TSOU NN
TATTERSALL FD
RUPNIAK NMJ
WILLIAMS AR
RYCROFT W
HARGREAVES R
MACINTYRE DE
Citation: Jj. Hale et al., STRUCTURAL OPTIMIZATION AFFORDING ENYL-4-(3-OXO-1,2,4-TRIAZOL-5-YL)METHYLMORPHOLINE, A POTENT, ORALLY-ACTIVE, LONG-ACTING MORPHOLINE ACETALHUMAN NK-1 RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 41(23), 1998, pp. 4607-4614
Authors:
RUPNIAK NMJ
TATTERSALL FD
WILLIAMS AR
RYCROFT W
CARLSON EJ
CASCIERI MA
SADOWSKI S
BER E
HALE JJ
MILLS SG
MACCOSS M
SEWARD E
HUSCROFT I
OWEN S
SWAIN CJ
HILL RG
HARGREAVES RJ
Citation: Nmj. Rupniak et al., IN-VITRO AND IN-VIVO PREDICTORS OF THE ANTIEMETIC ACTIVITY OF TACHYKININ NK1 RECEPTOR ANTAGONISTS, European journal of pharmacology, 326(2-3), 1997, pp. 201-209
Authors:
RUPNIAK NMJ
TATTERSALL FD
WILLIAMS AR
RYCROFT W
CARLSON EJ
CASCIERI MA
HALE JJ
MILLS SG
MACCOSS M
SEWARD E
HUSCROFT I
SWAIN CJ
HILL RG
HARGREAVES RJ
Citation: Nmj. Rupniak et al., PREDICTION OF THE ANTIEMETIC ACTIVITY OF NK1 RECEPTOR ANTAGONISTS IN FERRETS BY THEIR ABILITY TO INHIBIT GR73632-INDUCED FOOT TAPPING IN GERBILS, British Journal of Pharmacology, 120, 1997, pp. 363-363
Authors:
TATTERSALL FD
RYCROFT W
FRANCIS B
PEARCE D
MERCHANT K
MACLEOD AM
LADDUWAHETTY T
KEOWN L
SWAIN C
BAKER R
CASCIERI M
BER E
METZGER J
MACINTYRE DE
HILL RG
HARGREAVES RJ
Citation: Fd. Tattersall et al., TACHYKININ NK1 RECEPTOR ANTAGONISTS ACT CENTRALLY TO INHIBIT EMESIS INDUCED BY THE CHEMOTHERAPEUTIC AGENT CISPLATIN IN FERRETS, Neuropharmacology, 35(8), 1996, pp. 1121-1129
Authors:
LADDUWAHETTY T
BAKER R
CASCIERI MA
CHAMBERS MS
HAWORTH K
KEOWN LE
MACINTYRE DE
METZGER JM
OWEN S
RYCROFT W
SADOWSKI S
SEWARD EM
SHEPHEARD SL
SWAIN CJ
TATTERSALL FD
WATT AP
WILLIAMSON DW
HARGREAVES RJ
Citation: T. Ladduwahetty et al., N-HETEROARYL-2-PHENYL-3-(BENZYLOXY)PIPERIDINES - A NOVEL CLASS OF POTENT ORALLY-ACTIVE HUMAN NK1 ANTAGONISTS, Journal of medicinal chemistry, 39(15), 1996, pp. 2907-2914
Authors:
MASON GS
TATTERSALL FD
HILL RG
HARGREAVES RJ
Citation: Gs. Mason et al., EFFECT OF THE NK1 RECEPTOR ANTAGONISTS, L-733,060 AND CP-99,994, AND MORPHINE IN THE RABBIT SPINAL REFLEX PREPARATION, British Journal of Pharmacology, 117, 1996, pp. 242-242
Authors:
TATTERSALL FD
RYCROFT W
MARMONT N
CASCIERI M
HILL RG
HARGREAVES RJ
Citation: Fd. Tattersall et al., ENANTIOSPECIFIC INHIBITION OF EMESIS INDUCED BY NICOTINE IN THE HOUSEMUSK SHREW (SUNCUS-MURINUS) BY THE NEUROKININ(1) (NK1) RECEPTOR ANTAGONIST CP-99,994, Neuropharmacology, 34(12), 1995, pp. 1697-1699
Authors:
MACLEOD AM
CASCIERI MA
MERCHANT KJ
SADOWSKI S
HARDWICKE S
LEWIS RT
MACINTYRE DE
METZGER JM
FONG TM
SHEPHEARD S
TATTERSALL FD
HARGREAVES R
BAKER R
Citation: Am. Macleod et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF NK1 ANTAGONISTS DERIVED FROM L-TRYPTOPHAN, Journal of medicinal chemistry, 38(6), 1995, pp. 934-941
Authors:
TATTERSALL FD
RYCROFT W
HILL RG
HARGREAVES RJ
Citation: Fd. Tattersall et al., ENANTIOSELECTIVE INHIBITION OF APOMORPHINE-INDUCED EMESIS IN THE FERRET BY THE NEUROKININ(1) RECEPTOR ANTAGONIST CP-99,994, Neuropharmacology, 33(2), 1994, pp. 259-260
Authors:
TRICKLEBANK MD
BRISTOW LJ
HUTSON PH
LEESON PD
ROWLEY M
SAYWELL K
SINGH L
TATTERSALL FD
THORN L
WILLIAMS BJ
Citation: Md. Tricklebank et al., THE ANTICONVULSANT AND BEHAVIORAL PROFILE OF L-687,414, A PARTIAL AGONIST ACTING AT THE GLYCINE MODULATORY SITE ON THE N-METHYL-D-ASPARTATE(NMDA) RECEPTOR COMPLEX, British Journal of Pharmacology, 113(3), 1994, pp. 729-736
Authors:
TATTERSALL FD
RYCROFT W
HARGREAVES RJ
HILL RG
Citation: Fd. Tattersall et al., THE TACHYKININ NK(1) RECEPTOR ANTAGONIST CP-99,994 ATTENUATES CISPLATIN-INDUCED EMESIS IN THE FERRET, European journal of pharmacology, 250(1), 1993, pp. 180000005-180000006